In addition, we noticed increased PD-1 expression on CD8+ T cells in tumors of CB2-/- mice, an indication of high T cell activity against tumor antigens as well as a possible prediction of anti-PD-1 therapy response (25, 34, 52). This evidence concerns the gene CNR2 and neoplasm.